SCHEMBL16902194

SCHEMBL16902194

c1ccc(-c2cc(-c3ccccc3)cc(-c3cccc(-c4cccc(-c5ccc(-c6nc(-c7cccc(-c8ccccc8)c7)c7sc8ccccc8c7n6)cc5)c4)c3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 5/20 0.40
▸ PIM1 P11309 3/20 0.38
▸ PIM2 Q9P1W9 3/20 0.38
▸ PIM3 Q86V86 1/20 0.38
▸ TNKS O95271 3/20 0.38
▸ TNKS2 Q9H2K2 3/20 0.38
▸ PIK3CA P42336 2/20 0.38
▸ PI4KA P42356 1/20 0.38
▸ PI4KB Q9UBF8 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ RORB Q92753 1/20 0.36
▸ ADORA2A P29274 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ CDK5R1 Q15078 1/20 0.35
▸ ALOX5 P09917 1/20 0.35
▸ MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18370270 1.00 LIMK1 (0.40) LIMK1PIM1PIM2PIM3TNKS
SCHEMBL18017911 0.99 LIMK1 (0.41) LIMK1PIM1PIM2PIM3TNKS
SCHEMBL18370236 0.99 LIMK1 (0.41) LIMK1PIM1PIM2PIM3TNKS
SCHEMBL18017764 0.99 LIMK1 (0.41) LIMK1PIM1PIM2PIM3TNKS
SCHEMBL18017956 0.99 LIMK1 (0.41) LIMK1PIM1PIM2PIM3TNKS
SCHEMBL16902382 0.99 LIMK1 (0.41) LIMK1PIM1PIM2PIM3TNKS
SCHEMBL16902264 0.99 LIMK1 (0.41) LIMK1PIM1PIM2PIM3TNKS
SCHEMBL16902217 0.99 LIMK1 (0.41) LIMK1PIM1PIM2PIM3TNKS
SCHEMBL18017914 0.99 LIMK1 (0.41) LIMK1PIM1PIM2PIM3TNKS
SCHEMBL18017763 0.99 LIMK1 (0.41) LIMK1PIM1PIM2PIM3TNKS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170012216-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2017-01-12 — — US disclosed
US-20170012216-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2017-01-12 — — US disclosed
WO-2015105316-A1 FUSED-RING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 삼성에스디아이 주식회사 2015-07-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170012216-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 LIMK1 1263/4885PIM1 3689/4885PIM2 3667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback